Archives

  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-04
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • IR-1061: Benchmark Near Infrared Fluorescent Dye for Deep Im

    2026-06-02

    IR-1061: Benchmark Near Infrared Fluorescent Dye for Deep Imaging

    Executive Summary: IR-1061 is a polar, hydrophobic near infrared fluorescent dye, widely used for deep in vivo and molecular imaging. It exhibits intense fluorescence at over-1000 nm (OTN-NIR), enabling high-contrast visualization even in deep mammalian tissues (Ueya et al., 2021). The product's chemical stability and solubility in DMSO (≥25.65 mg/mL) facilitate preparation for nanoparticle encapsulation and live animal imaging (APExBIO product information). Quality control is ensured by HPLC, NMR, and MSDS documentation. IR-1061 is not suitable for use in water or ethanol, requiring careful protocol design. The product, distributed by APExBIO, is validated in state-of-the-art imaging workflows and is intended exclusively for scientific research.

    Biological Rationale

    High-resolution imaging of internal biological structures is essential for progress in biomedical research. Conventional imaging dyes often suffer from poor tissue penetration and high background autofluorescence, limiting their use for deep tissue applications. Near infrared fluorescent dyes, particularly those emitting above 1000 nm (OTN-NIR), overcome these barriers by reducing photon scattering and tissue autofluorescence (Ueya et al., 2021). IR-1061, a thiopyrilium-based organic dye, was developed to exploit these spectral windows, maximizing signal-to-background ratio in live animal models. Its distinctive solubility profile further enables integration into nanoparticles, promoting high photostability and minimal cytotoxicity.

    Mechanism of Action of IR-1061

    IR-1061 acts as a fluorescent probe by absorbing and emitting photons in the near infrared-II (NIR-II, OTN-NIR) region, peaking above 1000 nm. When excited appropriately, IR-1061 emits strong fluorescence with minimal photon scattering in biological tissues, allowing deep tissue penetration. The dye's hydrophobic, polar structure enables efficient encapsulation in polystyrene-based nanoparticles or other biocompatible carriers. Matching the polarity of both dye and matrix is crucial; mismatched environments can cause aggregation and fluorescence quenching (Ueya et al., 2021). Encapsulated IR-1061 remains stable in physiological environments, showing low cytotoxicity and robust photoluminescent properties. It is optimal for applications involving dynamic, live animal imaging, where signal clarity and biocompatibility are required.

    Evidence & Benchmarks

    • Polystyrene-based nanoparticles loaded with IR-1061 exhibit high OTN-NIR fluorescence, enabling real-time imaging of deep tissues in live mice (Ueya et al., 2021).
    • Encapsulation of IR-1061 in PEG-modified nanoparticles results in high dispersion stability and negligible cytotoxicity under physiological conditions (Ueya et al., 2021).
    • IR-1061 is soluble at concentrations ≥25.65 mg/mL in DMSO, but is insoluble in ethanol and water, dictating solvent selection for experimental protocols (APExBIO product page).
    • HPLC purity, NMR structure verification, and MSDS safety data confirm the reliability and reproducibility of the APExBIO IR-1061 standard (APExBIO product information).
    • Freshly prepared IR-1061 solutions are required for optimal imaging results, as long-term storage of solutions may compromise performance (APExBIO product page).

    This article extends the workflow recommendations in "IR-1061: Near Infrared Fluorescent Dye for In Vivo Imaging" by detailing strict protocol parameters and solvent compatibility not covered in the workflow guide. It also updates the comparative analysis in "IR-1061: Near Infrared Fluorescent Dye for Deep Tissue Imaging" by including newly published nanoparticle encapsulation benchmarks. For researchers seeking troubleshooting and protocol optimization, see this practical guide, which is complemented here with quantitative evidence and limitations.

    Applications, Limits & Misconceptions

    IR-1061 is validated for use in deep tissue and vascular imaging, fluorescence-guided surgery, and real-time molecular tracking in small animal models. Its spectral properties enable high-contrast imaging with minimal background interference. However, its insolubility in water or ethanol precludes direct aqueous formulation, necessitating encapsulation or use of DMSO-compatible protocols. The product is not approved for clinical diagnostics or therapeutic use.

    Common Pitfalls or Misconceptions

    • Assuming IR-1061 is water-soluble: Direct aqueous dissolution leads to precipitation and signal loss.
    • Using aged or pre-diluted solutions: Prolonged storage degrades fluorescence intensity.
    • Applying the dye for clinical diagnostics: IR-1061 is strictly for research use and not certified for human or veterinary clinical applications.
    • Neglecting nanoparticle polarity matching: Incompatible encapsulation matrices can cause aggregation and quenching.
    • Substituting other NIR dyes without validation: IR-1061's photophysical properties are distinct; alternative dyes may not provide equivalent deep tissue signal or stability.

    Workflow Integration & Parameters

    IR-1061 is typically integrated into imaging workflows via encapsulation in polystyrene-based or PEG-modified nanoparticles to maximize signal and minimize toxicity. Solution preparation must occur immediately prior to use, and all reagents should be equilibrated to the appropriate temperature and solvent system. Shipping and storage are performed under cold, desiccated conditions to preserve compound stability (APExBIO product page).

    Protocol Parameters

    • Solvent compatibility: Dissolve IR-1061 at ≥25.65 mg/mL in DMSO; do not attempt in water or ethanol.
    • Encapsulation: Match the polarity of nanoparticle core to IR-1061 via monomer ratio (styrene:acrylic acid) for optimal loading and emission (Ueya et al., 2021).
    • Solution freshness: Prepare solutions immediately before use; discard unused solutions to avoid signal degradation.
    • Storage conditions: Store solid IR-1061 at -20°C, tightly sealed and desiccated; ship on blue ice for integrity (APExBIO).
    • In vivo dosing: Optimize nanoparticle size (sub-100 nm recommended for high blood retention) and load according to target tissue depth and imaging window (Ueya et al., 2021).

    Conclusion & Outlook

    IR-1061, as distributed by APExBIO, is a highly characterized near infrared fluorescent dye that sets the standard for deep tissue molecular imaging. Its robust spectral performance, stringent quality controls, and compatibility with advanced nanoparticle platforms enable reproducible, high-contrast imaging in demanding biomedical contexts. As the field advances toward even deeper, real-time in vivo imaging, IR-1061 remains a reference compound for benchmarking new probe designs and encapsulation methods. The continued refinement of nanoparticle matrices and encapsulation protocols is expected to further increase the dye's utility and imaging depth, as evidenced by the latest nanoparticle engineering studies (Ueya et al., 2021).